| 7858658 |
Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
Anthony Kreft, Lynn Resnick, George Diamantidis, Derek Cecil Cole, Boyd L. Harrison +4 more |
2010-12-28 |
|
| 7713994 |
Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof |
Hwei-Ru Tsou, Semiramis Ayral-Kaloustian, Gary Harold Birnberg, Middleton B. Floyd, Jr., Joshua A. Kaplan +9 more |
2010-05-11 |
|
| 7629377 |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
David LeRoy Crandall, Eric Gould Gundersen, Hassan Mahmoud Elokdah |
2009-12-08 |
|
| 7550629 |
Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors |
Alexander Michael Porte, Thomas Joseph Caggiano, George Diamantidis, Diane Barbara Hauze, Boyd L. Harrison +5 more |
2009-06-23 |
$131,622,000 |
| 7547725 |
Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
Anthony Kreft, Lynn Resnick, George Diamantidis, Derek Cecil Cole, Boyd L. Harrison +4 more |
2009-06-16 |
$280,871,000 |
| 7514411 |
Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |
Robert E. McDevitt, Paul J. Dollings |
2009-04-07 |
$98,068,000 |
| 7446201 |
Substituted heteroaryl benzofuran acids |
Hassan Mahmoud Elokdah, Geraldine Ruth McFarlane |
2008-11-04 |
$59,766,000 |
| 7351730 |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
Eric Gould Gundersen, Hassan Mahmoud Elokdah, David LeRoy Crandall |
2008-04-01 |
$61,136,000 |
| 7300951 |
Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
Anthony Kreft, Lynn Resnick, George Diamantidis, Derek Cecil Cole, Boyd L. Harrison +4 more |
2007-11-27 |
$151,526,000 |
| 7132402 |
Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |
Robert E. McDevitt, Paul J. Dollings |
2006-11-07 |
$116,278,000 |
| 7081448 |
Benzyllactobionamides as inhibitors of smooth muscle cell proliferation |
— |
2006-07-25 |
$256,537,000 |
| 7008636 |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Eric Gould Gundersen +4 more |
2006-03-07 |
$92,854,000 |
| 6939886 |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
Eric Gould Gundersen, Hassan Mahmoud Elokdah, David LeRoy Crandall |
2005-09-06 |
$70,874,000 |
| 6849761 |
Substituted naphthoic acid derivatives useful in the treatment of insulin resistance and hyperglycemia |
Alan H. Katz |
2005-02-01 |
$258,288,000 |
| 6800654 |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
Eric Gould Gundersen, Hassan Mahmoud Elokdah, David LeRoy Crandall |
2004-10-05 |
$38,333,000 |
| 6765021 |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Eric Gould Gundersen +4 more |
2004-07-20 |
$287,757,000 |
| 6664243 |
Benzyllactobionamides as inhibitors of smooth muscle cell proliferation |
— |
2003-12-16 |
$121,986,000 |
| 6599925 |
Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
Hassan Mahmoud Elokdah, Geraldine Ruth McFarlane, David LeRoy Crandall |
2003-07-29 |
$267,507,000 |
| 6451827 |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Eric Gould Gundersen +4 more |
2002-09-17 |
$105,113,000 |
| 6340670 |
Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
Paul J. Dollings, Robert E. McDevitt |
2002-01-22 |
$213,378,000 |
| 6214877 |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Eric Gould Gundersen +4 more |
2001-04-10 |
|
